Page last updated: 2024-09-04

levofloxacin and Death, Sudden, Cardiac

levofloxacin has been researched along with Death, Sudden, Cardiac in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Pun, PH; Wang, L; Weber, DJ; Winkelmayer, WC1
Ahmadi, F; Garg, AX; Kim, RB; Knoll, GA; Muanda, FT; Silverman, MS; Sontrop, JM; Sood, MM; Weir, MA; Yoo, E1

Other Studies

2 other study(ies) available for levofloxacin and Death, Sudden, Cardiac

ArticleYear
Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure.
    Kidney international, 2022, Volume: 102, Issue:4

    Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Death, Sudden, Cardiac; Fluoroquinolones; Humans; Levofloxacin; Renal Dialysis; Renal Insufficiency; United States

2022
Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease.
    JAMA network open, 2022, 08-01, Volume: 5, Issue:8

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Cohort Studies; Death, Sudden, Cardiac; Female; Fluoroquinolones; Humans; Hypoglycemia; Levofloxacin; Norfloxacin; Ontario; Renal Dialysis; Renal Insufficiency, Chronic; Retinal Detachment; Sepsis

2022